Kolesnik, O.P. and Kuzmenko, V.O. 2020. ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer. Pathologia. 1 (May 2020). DOI:https://doi.org/10.14739/2310-1237.2020.1.203639.